Sharda Cropchem Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Sharda Cropchem Ltd. authored by Anand Rathi and published by - Trendlyne research reports.
Item: Sharda Cropchem Ltd.
Rating: 5
Author: Anand Rathi

Keep track of all breaking news and updates on Sharda Cropchem Ltd. from all sources in a single place.

Load latest

Sharda Cropchem Ltd.

10 Mar 2025

855.95

0.15%

Company Update

Sharda Cropchem Ltd - 538666 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Crisil Ratings has been reaffirmed its Crisil A1+ rating on the short term bank facilities of the Company.

pdf

Sharda Cropchem Ltd.

05 Mar 2025

855.95

0.15%

Growth momentum to sustain; maintaining a Buy

Buy: Sharda Cropchem Ltd.

Anand Rathi

We recently met Sharda Cropchem’s Chairman and MD, Mr R V Bubna to gauge the business outlook. Management is confident of achieving double-digit revenue growth (guidance raised 26% y/y post Q3 results vs. 15-20% earlier) in FY25, particularly due to volumes and penetration into new markets.

Sharda Cropchem Ltd. has gained 46.76% in the last 6 Months

Sharda Cropchem Ltd.

05 Feb 2025

855.95

0.15%

Company Update

Sharda Cropchem Ltd - 538666 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We would like to inform you that the officials of the Company will be meeting Investors/Analysts

pdf

Sharda Cropchem Ltd.

29 Jan 2025

855.95

0.15%

Company Update

Sharda Cropchem Ltd - 538666 - Disclosure Under Regulation 30 Of SEBI LODR Regulation 2015

BSE India

Disclosure under Regulation 30 of SEBI LODR Regulation 2015

pdf

Sharda Cropchem Ltd.

28 Jan 2025

855.95

0.15%

Company Update

Sharda Cropchem Ltd - 538666 - Disclosure Under Regulation 30 Of SEBI LODR Regulation 2015

BSE India

Disclosure under Regulation 30 of SEBI LODR Regulation 2015

pdf

Sharda Cropchem Ltd.

27 Jan 2025

855.95

0.15%

Decent show in Q3, growth momentum to continue; upgrading to a Buy

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

A gradual price increase, volume growth across regions and a good product mix drove Sharda Cropchem’s better-than-expected Q3 results. Growth would improve ahead as de-stocking is now complete

Sharda Cropchem Ltd. has gained 54.23% in the last 1 Year

Sharda Cropchem Ltd.

27 Jan 2025

855.95

0.15%

Volume fuels revenue, continued price recovery uplifts outlook

Buy: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

? Sharda Cropchem Limited (SCL) reported solid growth in 3Q FY25 as revenues increased by 46.9% y-o-y to Rs 929.3 crore, fuelled by a robust increase in sales volume and a strategic price adjustment. Growth was observed across regions, with Europe and North America exhibiting
strong performance.
? Gross margin expanded by 650 bps y-o-y to 32.7%.

Number of FII/FPI investors increased from 95 to 102 in Jun 2025 qtr.

Sharda Cropchem Ltd.

25 Jan 2025

855.95

0.15%

Company Update

Sharda Cropchem Ltd - 538666 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

The Company has published its unaudited financial results for the quarter and nine months ended 31st December, 2024 & intimation of record date in Newspaper today.

pdf

Sharda Cropchem Ltd.

25 Jan 2025

855.95

0.15%

Sharda Cropchem Q3 Results 2025 on 25 Jan, 2025: profit rise by 571.34% YOY, profit at 31.15 crore and revenue at 929.33 crore

livemint

Sharda Cropchem Q3 Results 2025 on 25 Jan, 2025: Revenue increased by 46.94% YoY & profit increased by 571.34% YoY, profit at 31.15 crore and revenue at 929.33 crore